pimonidazole has been researched along with Laryngeal Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
de Bree, R; H A M Kaanders, J; Philippens, MEP; Smits, HJG; Swartz, JE; Willems, SM | 1 |
Bussink, J; De Bree, R; Doornaert, PA; Hoogsteen, IJ; Kaanders, JH; Langendijk, JA; Oosterwijk, E; Rademakers, SE; Rijken, PF; Takes, R; Terhaard, CH; van den Ende, P; van der Kogel, AJ | 1 |
Bollineni, VR; Bruine de Bruin, L; de Bock, GH; Halmos, GB; Langendijk, JA; Pruim, J; Schuuring, E; Slagter-Menkema, L; Steenbakkers, RJ; van der Laan, BF; van der Wal, JE; van Hemel, BM; Wachters, JE | 1 |
Hoogsteen, IJ; Kaanders, JH; Lok, J; Marres, HA; Rijken, PF; Takes, RP; van der Kogel, AJ | 1 |
Balm, AJ; Begg, AC; Haustermans, KM; Hoebers, FJ; Hoefnagel, CA; Janssen, HL; Nunn, AD; Olmos, AV; Sprong, D | 1 |
Bussink, J; de Wilde, PC; Kaanders, JH; Marres, HA; Raleigh, JA; Rijken, PF; van den Hoogen, FJ; van der Kogel, AJ; Wijffels, KI | 1 |
3 trial(s) available for pimonidazole and Laryngeal Neoplasms
Article | Year |
---|---|
Correlation and colocalization of HIF-1α and pimonidazole staining for hypoxia in laryngeal squamous cell carcinomas: A digital, single-cell-based analysis.
Topics: Biomarkers; Biomarkers, Tumor; Cell Hypoxia; Head and Neck Neoplasms; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Laryngeal Neoplasms; Nitroimidazoles; Prognosis; Squamous Cell Carcinoma of Head and Neck; Staining and Labeling | 2022 |
Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Carbon Dioxide; Carbonic Anhydrase IX; Carbonic Anhydrases; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Niacinamide; Nitroimidazoles; Oxygen; Prognosis; Treatment Outcome | 2013 |
Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21.
Topics: Cell Hypoxia; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Injections, Intravenous; Laryngeal Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Nitroimidazoles; Normal Distribution; Organotechnetium Compounds; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
3 other study(ies) available for pimonidazole and Laryngeal Neoplasms
Article | Year |
---|---|
Assessment of hypoxic subvolumes in laryngeal cancer with (18)F-fluoroazomycinarabinoside ((18)F-FAZA)-PET/CT scanning and immunohistochemistry.
Topics: Aged; Aged, 80 and over; Biomarkers; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Hypoxia; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2015 |
Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Humans; Immunohistochemistry; Laryngeal Neoplasms; Male; Middle Aged; Nitroimidazoles; Radiation-Sensitizing Agents | 2009 |
Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas.
Topics: Aged; Biomarkers; Biopsy; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Hypoxia; Image Processing, Computer-Assisted; Immunohistochemistry; Laryngeal Neoplasms; Male; Microscopy, Fluorescence; Middle Aged; Nitroimidazoles; Oropharyngeal Neoplasms; Prognosis | 2000 |